Abstract
Turner syndrome (TS), characterized by the partial or complete absence of an X-chromosome, provides a unique insight into the role of the X-chromosome and the immune system. While women have a 10-fold higher incidence of autoimmune disease (AD) compared with men, the risk in women with TS is thought to be further doubled. TS is associated with a propensity for a wide variety of ADs that increase in incidence across the life span. Isochromosome Xq as well as isolated Xp deletion karyotypes may predispose to higher rates of AD in TS suggesting the impact of X-chromosome gene dosage. It is likely, however, that epigenetic changes across the genome and the hormonal milieu may also have a profound impact on the immune profile in TS. This review explores the immune phenotype and the spectrum of ADs in TS. Genotype-phenotype correlations are presented with a brief overview of the genetic and hormonal underpinnings.
References
1.
Bianchi
I
, Lleo
A
, Gershwin
ME
, Invernizzi
P
. The X chromosome and immune associated genes
. J Autoimmun
. 2012
;38
(2–3
):J187
–92
. 2.
Libert
C
, Dejager
L
, Pinheiro
I
. The X chromosome in immune functions: when a chromosome makes the difference
. Nat Rev Immunol
. 2010
;10
(8
):594
–604
. .3.
Gravholt
CH
, Andersen
NH
, Conway
GS
, Dekkers
OM
, Geffner
ME
, Klein
KO
, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 cincinnati international turner syndrome meeting
. Eur J Endocrinol
. 2017
;177
(3
):G1
–70
. .4.
Gawlik
AM
, Berdej-Szczot
E
, Blat
D
, Klekotka
R
, Gawlik
T
, Blaszczyk
E
, et al. Immunological profile and predisposition to autoimmunity in girls with turner syndrome
. Front Endocrinol
. 2018
;9
:307
. .5.
Chaplin
DD
. Overview of the immune response
. J Allergy Clin Immunol
. 2010
;125
(Suppl 2
):S3
–23
. .6.
Jensen
K
, Petersen
PH
, Nielsen
EL
, Dahl
G
, Nielsen
J
. Serum immunoglobulin M, G, and A concentration levels in turner’s syndrome compared with normal women and men
. Hum Genet
. 1976
;31
(3
):329
–34
. .7.
Cacciari
E
, Masi
M
, Fantini
MP
, Licastro
F
, Cicognani
A
, Pirazzoli
P
, et al. Serum immunoglobulins and lymphocyte subpopulations derangement in Turner’s syndrome
. J Immunogenet
. 1981 Oct
;8
(5
):337
–44
. .8.
Lorini
R
, Ugazio
AG
, Cammareri
V
, Larizza
D
, Castellazzi
AM
, Brugo
MA
, et al. Immunoglobulin levels, T-cell markers, mitogen responsiveness and thymic hormone activity in Turner’s syndrome
. Thymus
. 1983
;5
(2
):61
–6
.9.
Stenberg
AE
, Sylvén
L
, Magnusson
CG
, Hultcrantz
M
. Immunological parameters in girls with Turner syndrome
. J Negat Results Biomed
. 2004 Nov 25
;3
(1
):6
. .10.
Rongen-Westerlaken
C
, Rijkers
GT
, Scholtens
EJ
, van Es
A
, Wit
JM
, van den Brande
JL
, et al. Immunologic studies in Turner syndrome before and during treatment with growth hormone. The dutch growth hormone working group
. J Pediatr
. 1991
;119
(2
):268
–72
. .11.
Su
MA
, Stenerson
M
, Liu
W
, Putnam
A
, Conte
F
, Bluestone
JA
, et al. The role of X-linked FOXP3 in the autoimmune susceptibility of Turner syndrome patients
. Clin Immunol
. 2009
;131
(1
):139
–44
. .12.
Fan
H
, Wang
D
, Zhu
H
, Li
J
, Hu
Y
, Hou
Y
, et al. Lymphocyte subpopulations in chinese women with Turner syndrome
. Arch Gynecol Obstet
. 2012 Mar
;285
(3
):749
–55
. .13.
Lee
YA
, Kim
HR
, Lee
JS
, Jung
HW
, Kim
HY
, Lee
GM
, et al. CD4+ FOXP3+ regulatory T cells exhibit impaired ability to suppress effector T cell proliferation in patients with turner syndrome
. PLoS One
. 2015
;10
(12
):e0144549
. .14.
Robson
SC
, Potter
PC
. Common variable immunodeficiency in association with Turner’s syndrome
. J Clin Lab Immunol
. 1990
;32
(3
):143
–6
.15.
Al-Attas
RA
, Rahi
AH
, Ahmed
El
. Common variable immunodeficiency with CD4+ T lymphocytopenia and overproduction of soluble IL-2 receptor associated with Turner’s syndrome and dorsal kyphoscoliosis
. J Clin Pathol
. 1997 Oct
;50
(10
):876
–9
. .16.
Donti
E
, Nicoletti
I
, Venti
G
, Filipponi
P
, Gerli
R
, Spinozzi
F
, et al. X-ring Turner’s syndrome with combined immunodeficiency and selective gonadotropin defect
. J Endocrinol Invest
. 1989
;12
(4
):257
–63
. .17.
Markert
UR
, Vogelsang
H
, Jäger
L
. Selective T-cell deficiency in Turner’s syndrome
. J Investig Allergol Clin Immunol
. 2000 Sep–Oct
;10
(5
):312
–3
.18.
Ferrer Calvete
J
, Tomás
M
, Galmes
J
, Prieto
F
. Chronic diarrhea with selective IgA deficit associated with Turner’s syndrome
. An Esp Pediatr
. 1982
;16
(6
):459
–63
.19.
Kanakatti Shankar
R
, Loke
Y
. Pediatric endocrine society (PES) annual meeting
. Horm Res Paediatr
. 2020
.20.
Stagi
S
, Losi
S
, Chiarelli
F
, de Martino
M
, Falcini
F
. Kawasaki disease in a girl with Turner syndrome: a remarkable association
. Ital J Pediatr
. 2014 Feb 28
;40
(1
):24
. .21.
Swee
DS
, Spickett
G
, Quinton
R
. Many women with Turner syndrome lack protective antibodies to common respiratory pathogens, Haemophilus influenzae type B and Streptococcus pneumoniae
. Clin Endocrinol
. 2019
;91
(1
):228
–30
.22.
Jørgensen
KT
, Rostgaard
K
, Bache
I
, Biggar
RJ
, Nielsen
NM
, Tommerup
N
, et al. Autoimmune diseases in women with Turner’s syndrome
. Arthritis Rheum
. 2010
;62
(3
):658
–66
. .23.
Sokol
L
, Stueben
ET
, Jaikishen
JP
, Lamarche
MB
. Turner syndrome associated with acquired von Willebrand disease, primary biliary cirrhosis, and inflammatory bowel disease
. Am J Hematol
. 2002
;70
(3
):257
–9
. .24.
Goodyer
PR
, Fong
JS
, Kaplan
BS
. Turner’s syndrome, 46X, del (X) (p 11), persistent complement activation and membranoproliferative glomerulonephritis
. Am J Nephrol
. 1982
;2
(5
):272
–5
.25.
Sharief
R
, Miodovnik
A
, Motaghedi
R
. Seronegative myasthenia gravis, as a rare autoimmune condition in Turner syndrome
. Case Rep Pediatr
. 2017 Nov 14
;2017
:6863938
–4
. .26.
Stenberg
AE
, Sylvén
L
, Hedstrand
H
, Kämpe
O
, Hultcrantz
M
. Absence of autoantibodies connected to autoimmune polyendocrine syndrome type I and II and Addison’s disease in girls and women with Turner syndrome
. J Negat Results Biomed
. 2007 Dec 18
;6
(1
):10
. .27.
Goldacre
MJ
, Seminog
OO
. Turner syndrome and autoimmune diseases: record-linkage study
. Arch Dis Child
. 2014 Jan
;99
(1
):71
–3
. .28.
Cooney
CM
, Bruner
GR
, Aberle
T
, Namjou-Khales
B
, Myers
LK
, Feo
L
, et al. 46,X,del (X) (q13) Turner’s syndrome female with systemic lupus erythematosus in a pedigree multiplex for SLE
. Genes Immun
. 2009 May 1
;10
(5
):478
–81
.29.
Elsheikh
M
, Wass
JA
, Conway
GS
. Autoimmune thyroid syndrome in women with Turner’s syndrome: the association with karyotype
. Clin Endocrinol
. 2001 Aug
;55
(2
):223
–6
. .30.
Chiovato
L
, Larizza
D
, Bendinelli
G
, Tonacchera
M
, Marinó
M
, Mammoli
C
, et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner’s syndrome
. Eur J Endocrinol
. 1996
;134
(5
):568
–75
. .31.
Gawlik
A
, Gawlik
T
, Januszek-Trzciakowska
A
, Patel
H
, Malecka-Tendera
E
. Incidence and dynamics of thyroid dysfunction and thyroid autoimmunity in girls with Turner’s syndrome: a long-term follow-up study
. Horm Res Paediatr
. 2011 Nov
;76
(5
):314
–20
.32.
Mohamed
SOO
, Elkhidir
IHE
, Abuzied
AIH
, Noureddin
AAMH
, Ibrahim
GAA
, Mahmoud
AAA
, et al. Prevalence of autoimmune thyroid diseases among the Turner syndrome patients: meta-analysis of cross sectional studies
. BMC Res Notes
. 2018
;11
(1
):842
. .33.
Aversa
T
, Lombardo
F
, Valenzise
M
, Messina
MF
, Sferlazzas
C
, Salzano
G
, et al. Peculiarities of autoimmune thyroid diseases in children with Turner or down syndrome: an overview
. Ital J Pediatr
. 2015 May 15
;41
(1
):39
. .34.
Bakalov
VK
, Gutin
L
, Cheng
CM
, Zhou
J
, Sheth
P
, Shah
K
, et al. Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency
. J Autoimmun
. 2012
;38
(4
):315
–21
. .35.
Aversa
T
, Lombardo
F
, Corrias
A
, Salerno
M
, De Luca
F
, Wasniewska
M
. In young patients with Turner or down syndrome, graves’ disease presentation is often preceded by Hashimoto’s thyroiditis
. Thyroid
. 2014 Apr
;24
(4
):744
–7
. .36.
Valenzise
M
, Aversa
T
, Corrias
A
, Mazzanti
L
, Cappa
M
, Ubertini
G
, et al. Epidemiology, presentation and long-term evolution of Graves’ disease in children, adolescents and young adults with Turner syndrome
. Horm Res Paediatr
. 2014
;81
(4
):245
–50
. .37.
Aversa
T
, Messina
MF
, Mazzanti
L
, Salerno
M
, Mussa
A
, Faienza
MF
, et al. The association with Turner syndrome significantly affects the course of Hashimoto’s thyroiditis in children, irrespective of karyotype
. Endocrine
. 2015 Dec
;50
(3
):777
–82
. .38.
Bonamico
M
, Bottaro
G
, Pasquino
AM
, Caruso-Nicoletti
M
, Mariani
P
, Gemme
G
, et al. Celiac disease and Turner syndrome
. J Pediatr Gastroenterol Nutr
. 1998
;26
(5
):496
–9
. .39.
Marild
K
, Stordal
K
, Hagman
A
, Ludvigsson
JF
. Turner syndrome and celiac disease: a case-control study
. Pediatrics
. 2016
;137
(2
):e20152232
.40.
Larizza
D
, Calcaterra
V
, Martinetti
M
. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome
. J Autoimmun
. 2009
;33
(1
):25
–30
. .41.
Elsheikh
M
, Dunger
DB
, Conway
GS
, Wass
JA
. Turner’s syndrome in adulthood
. Endocr Rev
. 2002 Feb
;23
(1
):120
–40
. .42.
Bakalov
VK
, Cheng
C
, Zhou
J
, Bondy
CA
. X-chromosome gene dosage and the risk of diabetes in Turner syndrome
. J Clin Endocrinol Metab
. 2009
;94
(9
):3289
–96
. .43.
Watabe
H
, Kawakami
T
, Kimura
S
, Fujimoto
M
, Ono
T
, Mizoguchi
M
, et al. Childhood psoriasis associated with Turner syndrome
. J Dermatol
. 2006
;33
(12
):896
–8
. .44.
Brazzelli
V
, Larizza
D
, Martinetti
M
, Martinoli
S
, Calcaterra
V
, De Silvestri
A
, et al. Halo nevus, rather than vitiligo, is a typical dermatologic finding of Turner’s syndrome: clinical, genetic, and immunogenetic study in 72 patients
. J Am Acad Dermatol
. 2004
;51
(3
):354
–8
.45.
Zulian
F
, Schumacher
HR
, Calore
A
, Goldsmith
DP
, Athreya
BH
. Juvenile arthritis in Turner’s syndrome: a multicenter study
. Clin Exp Rheumatol
. 1998 Jul–Aug
;16
(4
):489
–94
.46.
Wihlborg
CE
, Babyn
PS
, Schneider
R
. The association between Turner's syndrome and juvenile rheumatoid arthritis
. Pediatr Radiol
. 1999
;29
(9
):676
–81
. .47.
Grossi
A
, Crinò
A
, Luciano
R
, Lombardo
A
, Cappa
M
, Fierabracci
A
. Endocrine autoimmunity in Turner syndrome
. Ital J Pediatr
. 2013
;39
(1
):79
. .48.
Larizza
D
, Martinetti Bianchi
M
, Lorini
R
, Maghnie
M
, Dugoujon
JM
, Cuccia Belvedere
M
, et al. Autoimmunity, HLA, Gm and Km polymorphisms in Turner’s syndrome
. Autoimmunity
. 2009
;4
(1–2
):69
–78
. .49.
Rydzewska
M
, Jaromin
M
, Pasierowska
IE
, Stożek
K
, Bossowski
A
. Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases
. Thyroid Res
. 2018 Feb 13
;11
:2
–9
. eCollection 2018
. .50.
Stoklasova
J
, Zapletalova
J
, Frysak
Z
, Hana
V
, Cap
J
, Pavlikova
M
, et al. An isolated Xp deletion is linked to autoimmune diseases in Turner syndrome
. J Pediatr Endocrinol Metab
. 2019
;32
(5
):479
–88
. .51.
Sarmiento
L
, Svensson
J
, Barchetta
I
, Giwercman
A
, Cilio
CM
. Copy number of the X-linked genes TLR7 and CD40L influences innate and adaptive immune responses
. Scand J Immunol
. 2019
;90
(2
):e12776
. .52.
Cook
KD
, Shpargel
KB
, Starmer
J
, Whitfield-Larry
F
, Conley
B
, Allard
DE
, et al. T follicular helper cell-dependent clearance of a persistent virus infection requires T cell expression of the histone demethylase UTX
. Immunity
. 2015
;43
(4
):703
–14
. .53.
Thrasher
BJ
, Hong
LK
, Whitmire
JK
, Su
MA
. Epigenetic dysfunction in turner syndrome immune cells
. Curr Allergy Asthma Rep
. 2016
;16
(5
):36
–6
. .54.
Trolle
C
, Nielsen
MM
, Skakkebæk
A
, Lamy
P
, Vang
S
, Hedegaard
J
, et al. Widespread DNA hypomethylation and differential gene expression in Turner syndrome
. Sci Rep
. 2016
;6
(1
):34220
. .55.
Zhang
X
, Hong
D
, Ma
S
, Ward
T
, Ho
M
, Pattni
R
, et al. Integrated functional genomic analyses of klinefelter and Turner syndromes reveal global network effects of altered X chromosome dosage
. Proc Natl Acad Sci U S A
. 2020 Mar 3
;117
(9
):4864
–73
. .56.
Rajpathak
SN
, Vellarikkal
SK
, Patowary
A
, Scaria
V
, Sivasubbu
S
, Deobagkar
DD
. Human 45,X fibroblast transcriptome reveals distinct differentially expressed genes including long noncoding RNAs potentially associated with the pathophysiology of Turner syndrome
. PLoS One
. 2014
;9
(6
):e100076
. .57.
Sharma
A
, Jamil
MA
, Nuesgen
N
, Schreiner
F
, Priebe
L
, Hoffmann
P
, et al. DNA methylation signature in peripheral blood reveals distinct characteristics of human X chromosome numerical aberrations
. Clin Epigenetics
. 2015
;7
(1
):76
. .58.
Lleo
A
, Moroni
L
, Caliari
L
, Invernizzi
P
. Autoimmunity and Turner’s syndrome
. Autoimmun Rev
. 2012
;11
(6–7
):A538
–43
. .59.
Bianco
B
, Verreschi
IT
, Oliveira
KC
, Guedes
AD
, Galera
BB
, Galera
MF
, et al. PTPN22 polymorphism is related to autoimmune disease risk in patients with turner syndrome
. Scand J Immunol
. 2010 Sep
;72
(3
):256
–9
. .60.
Desai
MK
, Brinton
RD
. Autoimmune disease in women: endocrine transition and risk across the lifespan
. Front Endocrinol
. 2019
;10
:265
. .61.
Moulton
VR
. Sex hormones in acquired immunity and autoimmune disease
. Front Immunol
. 2018
;9
:2279
. .62.
Wegiel
M
, Antosz
A
, Gieburowska
J
, Szeliga
K
, Hankus
M
, Grzybowska-Chlebowczyk
U
, et al. Autoimmunity predisposition in girls with turner syndrome
. Front Endocrinol
. 2019
;10
:511
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
